Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study.
Jung Ran ChoiJang-Young KimIl Hwan ParkJi Hye HuhKi Woo KimSeung Kuy ChaKyu Sang ParkJoon Hyung SohnJong Taek ParkSang Baek KohPublished in: Yonsei medical journal (2018)
Serum FGF21 level was an independent predictor for new-onset MetS in a population-based prospective study.